Foresite Capital Management Iv, LLC Kura Oncology, Inc. Transaction History
Foresite Capital Management Iv, LLC
- $153 Million
- Q3 2024
A detailed history of Foresite Capital Management Iv, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 1,849,947 shares of KURA stock, worth $16.5 Million. This represents 23.62% of its overall portfolio holdings.
Number of Shares
1,849,947
Previous 1,849,947
-0.0%
Holding current value
$16.5 Million
Previous $38.1 Million
5.1%
% of portfolio
23.62%
Previous 25.59%
Shares
5 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
81.8MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$68.4 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$62.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$51.9 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$48.4 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$38.7 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $598M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...